Bringing electromagnetic imaging research to patient’s bedside

Title of the research project 

EMERALD - ElectroMagnetic imaging for a novel genERation of medicAL Devices


EMERALD (“ElectroMagnetic imaging for a novel genERation of medicAL Devices”) is the coherent action of leading European engineering groups involved in electromagnetic (EM) technology for medical imaging to train a cohort of highly-skilled researchers capable of accelerating the translation of this technology “from research bench to patient bedside”.

Description of the research project 

Nowadays, medical imaging technologies play a key role to face the ever-growing number of challenges due to aging populations, as they are the essential clinical tool to deliver accurate initial diagnosis and monitor the evolution of disease over time. For this reason, a whole range of new imaging modalities is currently being developed to supplement and support current modalities. Among these technologies, there is EM imaging, which involves the illumination of the portion of the body under investigation with low-power non-ionizing EM waves (in the microwave spectrum) and the use of the resultant backscattered signals to generate images of the internal structures of the body.

The scientific objective pursued by the EMERALD action is to accelerate translation of research in EM medical imaging into clinical prototypes. To this end, EMERALD will establish a group of 13 outstanding early stage researchers who will be the European leaders in this field, through a unique scientific and training programme. The EMERALD trained researchers will drive the future developments of EM imaging technology, thanks to the targeted skills, they will attain, and their established connections with clinicians and stakeholders.

The EMERALD consortium involves academic institutions, industrial partners, hospitals and university medical centers (as partner organizations). The success of EMERALD will ensure that all achieved innovative technological developments will be translated into benefits to the end user community and potentially taken to market, with an impact on both the European society and scientific community.

Impact on researcher’s career and on society 

The EMERALD project will train world-class researchers who will be the future leaders in EM- based medical device development in Europe. The EMERALD training is based on the knowledge triangle between research, innovation and education, so to prepare the fellows for suitable career developments. Through close collaboration with industry partners and clinicians, these researchers will help to make Europe the most competitive knowledge-based environment to develop novel EM-based imaging devices. In the context of a worrying skills-shortage in the field, European industries, the European economy, and society in general, will benefit greatly from this unique group of highly trained experts.

Working group @Polito 

Francesca Vipiana, associate professor, Pproject coordinator

Mario Casu, associate professor

Jorge Tobon, postdoc researcher

Gianluca Dassano, Technician

List of beneficiary organizations 

National Research Council of Italy - IREA, Italy

National University of Ireland, Galway, Ireland

FCIENCIAS.ID Associacao para a Investigacao e Desenvolvimento de Ciencias, Portugal

Centre National de la Recherche Scientifique, France

Technical University in Ilmenau, Germany

Keysight Technologies Austria., Austria

King's College London, United Kingdom

WIPL-D, Serbia

Mitos Medical Technologies, Turkey


List of partner organizations 

Czech Technical University in Prague, Czech Republic

University of Belgrade, Serbia

Neurent Medical, Ireland

Institute of Telecommunications, Portugal

Medical Wireless Sensing Ltd, United Kingdom

University of Rome Sapienza, Italy

Italian National Agency for New Technologies, Energies and Sustainable Economic Development, Italy

Istanbul Technical University, Turkey

Johannes Kepler University Linz, Austria

European School of Antennas

University Hospital Bern, Swizerland

Hadassah Hebrew University Medical Center, Israel

University of Trento, Italy

Lariboisière University Hospital, Paris 7 University, France

Luz Saúde, S.A., Sociedade Aberta Hospital da Luz, Portugal

Faculdade de Ciencias da Universidade de Lisboa, Portugal

Sorbonne Université, France

EMERALD project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 764479

  • Budget: 3.300.160 euro
  • Start date: 1/05/2018
  • End date: 30/04/2022